We're close to the world's first-ever broad-spectrum antiviral, which could be deployed against future pandemic threats.

In a breakthrough, researchers at the City University of New York have identified a promising path to the development of an antiviral that could be used to fight a wide range of deadly viruses.

"Currently, if a new viral outbreak occurs from a new virus (or some old viruses like measles or influenza), we often don't have vaccines or antivirals that are effective against those diseases, so a deadly pandemic can occur," study author and nanoscience professor, Adam Braunschweig, told Newsweek .

"Even if new vaccines and antibodies can be developed, this could take months-to-years and during that time the ill consequences of the disease spread."

Unlike bacterial infect

See Full Page